Jaguar Health, Inc. (JAGX) is a publicly traded Healthcare sector company. As of May 21, 2026, JAGX trades at $3.44 with a market cap of $1.90M and a P/E ratio of -0.16. JAGX moved +0.00% today. Year to date, JAGX is -88.80%; over the trailing twelve months it is -98.02%. Its 52-week range spans $2.53 to $1,121.59. Rallies surfaces JAGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
JAGX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. JAGX recently traded at $3.44. Market cap is $1.90M. P/E ratio is -0.16. Revenue is $11.51M.
| Metric | Value |
|---|---|
| Price | $3.44 |
| Market Cap | $1.90M |
| P/E Ratio | -0.16 |
| EPS | $-22.97 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,121.59 |
| 52-Week Low | $2.53 |
| Volume | 29.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.51M |
| Net Income | $-54.00M |
| Gross Margin | 67.21% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $11.51M | $-54.00M | $-22.97 |
| 2024 | $11.69M | $-39.25M | $-130.69 |
| 2023 | $9.76M | $-41.90M | $-1.79 |
| 2022 | $11.96M | $-48.40M | $-36.18 |
JAGX analyst coverage data. Average price target: $0.00.